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Bovine leukemia virus (BLV) is the causative agent of bovine leukosis, a naturally occurring fatal disease in cattle. BLV
transcription is regulated by cellular transcription factors and the virally encoded oncoprotein Tax. In this report, we
investigated the functional role of the putative NF-kB binding site recently identified in the BLV promoter. Our studies indicate
that the kB binding motif acts as a functional enhancer in the presence of the cellular NF-kB proteins. Furthermore, the kB
site together with a single 21-bp repeat confers strong activation of BLV transcription in the presence the NF-kB proteins and
Tax. These results suggest that cellular NF-kB may be involved in the regulation of BLV transcription and activation of the
virus from latency. © 1998 Academic Press
INTRODUCTION
Bovine leukemia virus (BLV) is a B-lymphocytotropic
oncogenic retrovirus which causes preneoplastic (per-
sistent lymphocytosis) and neoplastic (leukemia/lym-
phoma) disease in cattle. Activation of the host B cell and
BLV replication appear to be linked, but the mechanisms
by which they are initiated remain unclear. It is well
established that the CREB/ATF family of transcription
factors bind to the 21-base-pair (bp) repeats in the BLV
promoter and that these factors interact with the BLV
transactivating protein Tax to activate viral transcription
(Derse and Casey, 1986; Katoh et al., 1989; Willems et al.,
1992). However, in the absence of Tax, the viral genome
is transcribed at low or undetectable levels. During this
latent phase of BLV infection, cellular transcription fac-
tors other than the CREB/ATF proteins may control the
initial phase of viral transcription (Jensen et al., 1990). We
have recently identified an NF-kB binding site in the BLV
promoter, which we hypothesize may be involved in BLV
transcriptional activation in the absence of Tax (Brooks
et al., 1995).
The NF-kB family of sequence-specific DNA binding
proteins are constitutively expressed in B cells, the target
cell for BLV infection. NF-kB proteins bind to kB en-
hancer elements found in many cellular genes, including
those for the immunoglobulin k light chain, IL-2, and
IL-2Ra (reviewed in Bose, 1992). NF-kB proteins also
interact with the human immunodeficiency virus (HIV),
where their effects on viral replication have been exten-
sively studied (Nabel and Baltimore, 1987; Bo¨hnlein et al.,
1989; Bruder et al., 1993; Atwood et al., 1994; Roulston et
al., 1995). The NF-kB proteins are also among the cellular
factors through which the human T-cell leukemia virus,
type I (HTLV-I) Tax protein mediates transactivation of
cellular and viral genes (Hiscott et al., 1995).
In this study, we characterized the role of the NF-kB
proteins on BLV transcription, in both the presence and
the absence of the BLV transactivating protein Tax. We
hypothesized that increased expression of NF-kB pro-
teins resulting from any type of immune-mediated B-cell
activation (Liou et al., 1994) would cause expression of
latent virus in activated B cells coincidentally infected
with BLV. Subsequent increased expression of Tax would
further enhance BLV replication. We demonstrate that
NF-kB heterodimers p49/p65 and p50/p65 stimulate BLV
expression in the absence of Tax and further activate
BLV transcription in the presence of Tax. Stimulation of
the BLV promoter by the NF-kB proteins occurred
through the kB binding site, which is located between
the middle and promoter proximal Tax-responsive 21-bp
repeats. These results suggest that the NF-kB proteins in
BLV-infected B cells may regulate viral transcription, pos-
sibly promoting reactivation of the latent virus.
RESULTS AND DISCUSSION
NF-kB proteins activate transcription through the BLV
kB site
We have previously shown that the BLV kB site binds
NF-kB family members and enhances transcription in
response to phorbol myristate acetate (Brooks et al.,
1995). To test whether the BLV kB element is directly
activated by NF-kB proteins, we tested a chimeric-CAT
reporter construct which carries three copies of the BLV
kB enhancer element cloned upstream of the SV40 pro-
moter (pCATPNFLTR, Fig. 1) (see Brooks et al., 1995). To
† Deceased.
1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (970) 491-0494. E-mail: jnyborg@vines.colostate.edu.
VIROLOGY 243, 94–98 (1998)
ARTICLE NO. VY989035
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
94
determine whether the BLV kB site confers transcrip-
tional responsiveness to the NF-kB proteins, transient
transfection assays were performed in CV-1 cells, in the
absence or the presence of expression plasmids for p49,
p50, or p65. Transcription was unaffected by p49 and p50
alone and only modestly stimulated by p65 alone (2-fold)
(data not shown). p65 stimulation may have resulted from
homodimerzation or heterodimerization with endoge-
nous proteins. The absence of a transactivation domain
in p50 and p49 likely accounts for the negative results
obtained with these NF-kB proteins (Thanos and Mania-
tis, 1995). Cotransfection with both p49 and p65 stimu-
lated pCATPNFLTR expression approximately 2-fold (Fig.
2, compare lanes 7 and 8 with lanes 9 and 10), and
cotransfection with both p50 and p65 stimulated pCAT-
PNFLTR expression 10-fold (Fig. 2, compare lanes 7 and
8 with lanes 11 and 12). The NF-kB expression plasmids
had no effect on expression of the parent plasmid
pCAT-P, which does not contain the BLV kB binding motif
(Fig. 2, lanes 1–6). These data indicate that the BLV kB
binding site mediates transcriptional activation in the
presence of the p49/p65 and p50/p65 heterodimers.
The BLV NF-kB enhancer does not mediate tax
transactivation
The HTLV-I Tax protein has been shown to activate
transcription through two kB sites in the HIV promoter
(Nabel and Baltimore, 1987; Siekevitz et al., 1987). To test
whether the BLV kB sites are Tax responsive, we exam-
ined pCATPNFLTR transcription in the absence and the
presence of cotransfected BLV Tax and NF-kB expres-
sion plasmids. Figure 3 shows that expression of BLV
Tax had no effect on the transcriptional activity of the
chimeric BLV kB reporter plasmid, in either the absence
or the presence of NF-kB proteins.
The NF-kB proteins activate transcription from the
BLV promoter
Previous studies have shown that the BLV promoter is
strongly activated by Tax and that Tax transactivation is
dependent upon the 21-bp CREB binding sites (Derse,
1987; Katoh et al., 1989). We were interested in testing
whether the BLV kB site might also contribute to the
transcriptional responsiveness of the BLV promoter in
either the presence or the absence of Tax. Transient
cotransfection assays were performed using both full-
length and deletion constructs of the BLV promoter
linked to the CAT gene. As shown in Fig. 4, basal tran-
scription from the full BLV promoter containing the 21-bp
FIG. 1. Schematic representation of the CAT (chloramphenicol acetyl-
transferase) reporter plasmid, pCATPNFLTR, which contains three cop-
ies of the kB binding site from the BLV promoter cloned into pCAT-P
(pCAT-P, Promega Corp., Madison, WI). The construction of this reporter
plasmid has previously been described (Brooks et al., 1995). Hatched
boxes represent three copies of the BLV kB site.
FIG. 2. Transient cotransfection assays using pCATPNFLTR in the presence of expression plasmids for the NF-kB proteins p49/p65 or p50/p65. CV-1
cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum. Subconfluent cells were cotransfected
with reporter and expression plasmids in serum-free DMEM using Lipofectin (Life Technologies, Inc., Gaithersburg, MD). Cells were harvested 72 h
later and extracts were assayed for CAT enzyme activity as previously described (Gorman et al., 1982). CAT activity was detected by thin-layer
chromatography and quantitated by Phosphorlmager analysis. The parent plasmid, pCAT-P, which does not carry the kB sites, was used as a negative
control.
95BLV TRANSCRIPTION IS REGULATED BY NF-kB PROTEINS
repeats was relatively weak (Fig. 4, lane 1). However,
transcription was progressively enhanced in the pres-
ence of cotransfected NF-kB p50/65 heterodimer (Fig. 4,
lane 2), BLV Tax (Fig. 4, lane 3), or both (Fig. 4, lane 4). To
determine whether the BLV kB motif, located between
nucleotides 2118 and 270, conferred transcriptional re-
sponsiveness in the presence of the p50/p65 het-
erodimer, we analyzed a series of BLV promoter 59 de-
letion mutants. Deletion of the first [pBLP2S(2143)] and
second [pBLP1S(2118)] proximal 21-bp repeats progres-
sively reduced Tax transactivation (Fig. 4, compare lanes
3, 7, and 11), without dramatically affecting transcription
in the presence of the NF-kB proteins (Fig. 4, compare
lanes 2, 6, and 10). Significantly, transcription observed in
the presence of both the NF-kB proteins and Tax was
unaffected by these deletions (Fig. 4, compare lanes 4, 8,
and 12). Further deletion through a portion of the kB site
[pBLRS(298)] dramatically reduced promoter respon-
siveness to the NF-kB proteins alone (Fig. 4, compare
lanes 10 and 14) and in combination with cotransfected
Tax (Fig. 4, compare lanes 12 and 16). Similar results
were obtained with cotransfection of the p49/p65 pro-
teins (data not shown). These results indicate that the
BLV promoter is functionally responsive to the NF-kB
proteins in the absence of Tax. Furthermore, the kB
element appears to cooperate with a single 21-bp repeat
to enhance transcription in the presence of Tax.
The BLV transcriptional control region carries three
21-bp repeat enhancer elements and an NF-kB binding
site. The Tax-responsive 21-bp repeats are critical for
efficient BLV replication; however in the latent phase of
BLV infection, both the Tax protein and viral transcription
are undetectable. This state of viral latency is paradoxi-
cal, as efficient BLV transcription requires Tax, yet the
initial phase of viral transcription must occur in the ab-
sence of Tax. In this report, we investigated a possible
FIG. 3. Transient cotransfections in CV-1 cells using pCATP or pCAT-
PNFLTR and the indicated NF-kB proteins. Transfection assays were
performed in the absence or the presence of the BLV Tax expression
plasmid pRSV-Tax-BLV as indicated.
FIG. 4. Transient cotransfections in CV-1 cells were performed with the following CAT reporter plasmids containing deletions in the BLV promoter:
pBLS1(2179 bp), pBLP2S(2143 bp), pBLP1S(2118 bp), pBLRS(298 bp), and pBLHS(254 bp) (Derse, 1987). Numbers in parentheses indicate position
(base pairs) of 59 deletion upstream from the BLV transcriptional start site. Promoter deletion constructs were assayed in the absence or the presence
of the expression plasmids for BLV Tax and the NF-kB proteins p50 and p65, as indicated for each lane. Percentages and relative CAT activation are
shown across the top.
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role for the NF-kB proteins in BLV transcriptional activa-
tion in the absence of Tax. We show that a chimeric
promoter carrying the isolated BLV NF-kB binding site
can act as a transcriptional enhancer in response to the
specific NF-kB proteins p50/p65 and p49/p65. Cotrans-
fection of the BLV Tax expression plasmid in the pres-
ence of p50/p65 or p49/p65 heterodimers did not further
stimulate expression from the kB chimeric promoter
(pCATPNFLTR). This observation is not unexpected, as
recent reports suggest that the HTLV-I Tax protein may
activate NF-kB proteins via proteolytic processing and/or
release of these proteins from their cytoplasmic inhibitor,
IkB (Suzuki et al., 1993, 1994). If BLV Tax also functions at
the level of NF-kB proteolytic maturation, it would show
no effect in the presence of the expression plasmids for
mature kB proteins, particularly in a nonlymphoid cell
line such as CV-1. Further studies will be required to
clarify potential interactions between BLV Tax and the
NF-kB proteins.
We also provide data indicating that the BLV kB en-
hancer region is responsive to the NF-kB proteins in the
context of the natural BLV promoter and that this respon-
siveness is independent of BLV Tax. Deletion of the kB
element in the BLV promoter (located between 2118 and
270) significantly reduced transcription in the presence
of the cotransfected NF-kB proteins p50/p65 and p49/
p65. We also provide data showing that the kB element
and a single 21-bp repeat are sufficient for strong acti-
vation of BLV transcription in the presence of NF-kB and
Tax. This finding is intriguing, as the three 21-bp repeats
have classically been considered the primary target for
Tax transactivation (Derse, 1988; Willems et al., 1990).
In summary, we demonstrate that the interaction of the
NF-kB proteins with their kB binding site in the BLV
promoter may play a role in the regulation of BLV tran-
scription. Since Tax expression is usually undetectable
during viral latency in the infected B lymphocyte, the
endogenous NF-kB proteins may provide the initial stim-
ulation of BLV transcription. This early BLV transcription
would lead to increased synthesis of Tax, and the pres-
ence of both Tax and NF-kB would synergistically acti-
vate BLV transcription, leading to high-level virion pro-
duction.
MATERIALS AND METHODS
Recombinant plasmids
The CAT (chloramphenicol acetyltransferase) reporter
plasmid pCATPNFLTR contains three copies of the BLV
kB site cloned into pCAT, as previously described
(Brooks et al., 1995). The pCAT-P promoter vector, without
the kB sites, was used as a negative control. A BLV Tax
expression plasmid (pRSV-Tax-BLV) and full-length and
deletion mutants [pBLS1(2179 bp), pBLP2S(2143 bp),
pBLP1S(2118 bp), pBLRS(298 bp), and pBLHS(254 bp)]
of the BLV promoter have been described previously and
were provided by Dr. David Derse (Derse, 1987). The
NF-kB expression plasmids pRSV-NF-kB2 (p49), pRSV-
NF-kB1 (p50), and pRSV-Re1A (p65) were obtained from
the AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH (Schmid et al., 1991; Perkins
et al., 1992; Duckett et al., 1993).
Cell culture, transfection, and CAT assays
CV-1 cells (ATCC CCL70) were propagated in Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum. Subconfluent cultures were
cotransfected with reporter and expression plasmids in
serum-free DMEM using Lipofectamine (Life Technolo-
gies, Inc., Gaithersburg, MD). Cells were harvested 72 h
after transfection and lysed in 0.25 M Tris–HCl buffer by
three successive rapid freeze/thaw cycles. Cell lysates
were assayed for CAT enzyme activity, and the percent-
age of acetylated 14C-labeled chloramphenicol was de-
termined by Phosphorlmager analysis (Gorman et al.,
1982, 1983).
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